Follow Living With Achalasia:

  • Facebook Clean Grey

Fax : 972-692-0426

Tel : 214-531-7939

© 2015 by Deserve Victory LLC. Proudly created with Wix.com

December 12, 2019

October 21, 2015

Please reload

Recent Posts

POEM Update

December 12, 2019

1/10
Please reload

Featured Posts

Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial

October 9, 2015

More on the benefits of probiotics. Read here.

 

  • In total, 63% of patients receiving BB536 showed clinical remission (UC disease activity index [UCDAI] ≤ 2) at week 8 compared to 52% of those receiving placebo (P=0.395).

  • The authors observed a significant decrease of UCDAI scores (3.5±1.9 at baseline to 2.5±1.7 at week 8) in the BB536 group (P<0.01), while there was no significant decrease in the placebo group (P=0.88).

  • There was also a significant decrease in the Rachmilewitz endoscopic index (EI) and the Mayo sub-score at week 8 in the BB536 group, while there was no significant decrease in the placebo group.

  • Besides the single patient in the BB536 group who complained of a mild side effect, no other adverse effects were observed.

     

     

     

     

     

     

     

     

     

Please reload

Follow Us
Search By Tags